Large-scale testing (Phase 3)Study completedNCT00623428
What this trial is testing
Combination Therapy With PEGASYS (Pegylated Interferon Alfa-2a (40KD)) and Copegus (Ribavirin) in Patients With Chronic Hepatitis C Genotype 2 or 3 Who Do Not Achieve a Rapid Viral Response
Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 235